By
Adrianne Appel2022-11-30T18:56:00
LegacyXChange had its securities revoked by the Securities and Exchange Commission (SEC) for failing to file required reports to the agency for four years.
Legacy is an inactive shell company that operates an online platform for buying and selling sports-related products through live auction. After filing to go public in April 2016, Legacy notified the SEC in June 2016 it would be completing its first report late.
“[B]etween July 2016 and November 2020, Legacy failed to file that report, any other required periodic reports, or any additional Forms 12b-25 to notify the commission that it needed additional time to file its periodic reports,” the SEC said in an administrative proceeding Tuesday.
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
2026-02-06T15:34:00Z By Tom Fox
When a company rapidly adopts AI, compliance officers can be blindsided, tasked with governance almost immediately. Luckily, there is a guide from the U.S. Department of Justice to help.
2026-02-05T23:22:00Z By Oscar Gonzalez
At Compliance Week’s recent Artificial Intelligence and Compliance event, one message came through clearly: Companies are moving quickly to adopt AI, while compliance programs are still trying to catch up.
2026-02-05T23:12:00Z By Adrianne Appel
The Financial Industry Regulatory Authority (FINRA) has welcomed artificial intelligence (AI) with open arms—and also caution.
2026-02-05T00:55:00Z By Ruth Prickett
Major accountancy firms in France are under investigation for anti-competitive practices. The French competition watchdog embarked on a series of “unannounced inspections” and removed documents relating to audit and reporting on Jan. 13.
2026-02-03T23:22:00Z By Neil Hodge
The European Commission has launched a formal investigation against Elon Musk’s X under the Digital Services Act over fears that its AI tool Grok may be producing and disseminating illegal material.
2026-02-03T22:57:00Z By Adrianne Appel
Three former executives at Archer-Daniels-Midland intentionally misled investors by inflating the performance of the company’s Nutrition unit, the U.S. Securities and Exchange Commission has alleged.
Site powered by Webvision Cloud